Dr David Fackrell
/content/dam/genesiscare/headshots/uk-doctor-headshots/UK_Oncology_Head_shot_GA_David_Fackrell.jpg

Dr David Fackrell

Dr David Fackrell
David
Fackrell
BSc. Genetis, MBChB, MRCP, FRCR, Consultant Clinical Oncologist

Languages spoken

English

Expert in

Urological (prostate, bladder and kidney) and upper gastrointestinal

Overview

Dr David Fackrell qualified in medicine from the University of Warwick in 2006. However, his interest in oncology started before this whilst studying for a Bachelor of Science degree in genetics at the University of Liverpool. David now specialises in the treatment of urological (prostate, bladder and kidney) and upper gastrointestinal (oesophagus and stomach) cancers.

He was appointed a consultant at University Hospital Birmingham in 2017 and now holds positions at The University of Birmingham and The Royal College of Radiologists. An active member of research in all the cancers he treats, David has published a number of peer reviewed papers, book chapters and reports and has also presented nationally and internationally. He also has a keen interest in medical education.

David’s patients value his empathy. He works hard to ensure his patients and involved in the decisions being made and understands their diagnosis and treatment plan fully.

Career positions

Current position(s)
  • Consultant Clinical Oncologist at University Hospital Birmingham and The Royal College of Radiologists

Education

Universities
  • Bachelor of Science degree in genetics at the University of Liverpool
  • Medicine from the University of Warwick in 2006

Accomplishments

Awards

  • Post Graduate Award in Professional Skills in Healthcare. University of Warwick. August 2008
  • Diploma in Clinical Oncology. University of Birmingham. June 2012

Expertise and interests

Expertise
  • Urological (prostate, bladder and kidney) cancers
  • Upper gastrointestinal (oesophagus and stomach) cancers
Interests
  • Prostate cancer
  • Bladder cancer
  • Kidney cancer
  • Oesophageal Cancer
  • Stomach cancer
  • Medical education

Publications

  • Fackrell, D. Kirby, P. Sanghera and A. Hartley. (2015). The effect of silver sulfadiazine and zinc oxide creams on dose distribution during radiotherapy. Journal of Radiotherapy in Practice. DOI: https://doi.org/10.1017/S1460396914000533
  • Fackrell, D. Ford, S. Cheti, S. Austin and N. James. (2016). The delivery of radical radiotherapy to the bladder and pelvis in node positive (N1) bladder cancer. A five patient case series. BJR Case Reports. http://dx.doi.org/10.1259/bjrcr.20160102
  • Fackrell, D. (2017).  Medical Student-led Outpatient Clinics: Improving Undergraduate Oncology Education. Clinical Oncology.
  • David Fackrell, Anjali Zarkar et al. (2018). Radical treatment of muscle-invasive bladder cancer—are options equal? J Radiat Oncol
  • Chapter 11 Bladder Cancer. Radiotherapy in practice – External beam therapy. ISBN 978-0-19-878675-7

Professional memberships

  • Member of the Royal College of Physicians of the United Kingdom – November 2009
  • Fellow of the Royal College of Radiologists of the United Kingdom – May 2016